SriJObulareddyMD
Oncology • Little Rock, ARBreast Cancer, Hematologic Oncology, Thoracic Cancer
Hematologist/Oncologist
Dr. Obulareddy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4301 W Markham St
Little Rock, AR 72205Phone+1 501-296-1200
Education & Training
University of Texas Medical Branch HospitalsFellowship, Medical Oncology, 2014 - 2016- University of Texas Medical Branch HospitalsResidency, Internal Medicine, 2011 - 2014
Stephen F. Austin State UniversityMS, Occupational Medicine, Environmental Health, 2006 - 2009- Stephen F. Austin State UniversityM.S., Occupational and Environmental Health, 2006 - 2009
Andhra Medical College NTRClass of 2004
Certifications & Licensure
AR State Medical License 2022 - 2025
WA State Medical License 2017 - 2024
ND State Medical License 2016 - 2023- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Best overall clinical research award The University of Texas Medical Branch, 2012
Publications & Presentations
PubMed
- Glucagon-like peptide-1 agonists in cardiovascular diseases: a bibliometric analysis from inception to 2023.Abinash Mahapatro, Ali Bozorgi, Sri U J Obulareddy, Shika M Jain, Rohan Reddy Korsapati
Annals of Medicine and Surgery. 2024-11-01 - The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.Gautam Maddineni, Sri J Obulareddy, Ruchir D Paladiya, Rohan R Korsapati, Shika Jain
Annals of Medicine and Surgery. 2024-08-01 - Stem Cell Origin of Cancer: Clinical Implications beyond Immunotherapy for Drug versus Therapy Development in Cancer Care.Shi-Ming Tu, Anup K Trikannad, Sruthi Vellanki, Munawwar Hussain, Nazish Malik
Cancers. 2024-03-14
Journal Articles
- Trends of MRI use to Evaluate Breast Cancer in the Texas Medicare PopulationTechksell M Washington1, Solly Silwan Chedid1*, Wei Zhang1, Celia Chao1, Sri Obulareddy1, Yong-Fang Kuo1,2, Catherine Cooksley1,2 and Gulshan Sharma, Journal of Cancer Prevention and Current Research, 10/31/2016
- Phase 1 study of Pazopanib and Ixabepilone in Patients with Solid Tumors: To determine the optimal tolerated regimen (OTR) of combination Pazopanib and Ixabepilone dur...Ganesan C, Obulareddy SJ, Fischer J, Pharm D, Antonysamy M, Jha G, Bliss R, Dudek A, American Journal of Clinical Oncology, 1/1/2016
- Phase I Study of Pazopanib and Ixabepilone in Patients With Solid TumorsGanesan C, Obulareddy SJ, Fischer JH, Antonysamy MA, Jha G, Bliss RL, Dudek AZ., American Journal of Clinical Oncology, 2/2014
- Join now to see all
Lectures
- Phase 1 study of Pazopanib and Ixabepilone in Patients with Solid Tumors: To determine the optimal tolerated regimen (OTR) of combination Pazopanib and Ixabepilone dur...Washington, DC, 2013; University of Texas Medical Branch, Galveston, TX, 2013 - 1/1/2013
- Annual Foot Exam in patients with type -2 Diabetes MellitusUniversity of Texas Medical Branch, Galveston, TX - 1/1/2013
Press Mentions
Board-Certified Oncologist Sri Obulareddy, M.D., Joins UAMS Winthrop P. Rockefeller Cancer InstituteFebruary 22nd, 2023
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Hindi, Telugu
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
